| Excipeints Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Physicochemical and Microbiological Stability of Commonly Prescribed APIs in SyrSpend® SF PH4: A Comprehensive Compatibility Study
Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
|
May/Jun 2025
Pg. 222-238
|
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line
Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson Caetano
|
May/Jun 2025
Pg. 239-253
|
Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone
Kegele Carolina Schettino, Ferreira Anderson de Oliveira, Koulouridas Savvas, Polonini Hudson
|
Jan/Feb 2025
Pg. 77-84
|
Extemporaneous Compounding of Medicated Ointments
Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
|
Nov/Dec 2024
Pg. 460-467
|
Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 376-381
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 296-297
|
Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L, Williams LaVonn A
|
May/Jun 2024
Pg. 226-227
|
Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
|
Nov/Dec 2023
Pg. 454-460
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 522-527
|
Excipients and Adverse Events
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 382-385
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
|
Sep/Oct 2023
Pg. 431-439
|
Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn Scar Management
Heuerman Jason, Haiub Halema, Cull Erica, Lupatini Rodrigo, Shrum Brandon, Sidhu Raman
|
Jul/Aug 2023
Pg. 270-276
|
Topical Vehicles: A Dermatologist's Perspective
Adame Stephanie, Collins Michael E, Korman Abraham M
|
Jul/Aug 2023
Pg. 278-283
|
Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 295-302
|
Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 329
|
Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt
Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2023
Pg. 330-339
|
Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
|
May/Jun 2023
Pg. 218-221
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
|
May/Jun 2023
Pg. 240-249
|
Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
|
May/Jun 2023
Pg. 250-255
|
Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
|
May/Jun 2023
Pg. 256-262
|
Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 149-151
|
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarum K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Mar/Apr 2023
Pg. 160-168
|
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
|
Jan/Feb 2023
Pg. 6-10
|
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
|
Jan/Feb 2023
Pg. 24-29
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 52
|
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 53
|
Suspension Solution, Sugar Free
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 58-59
|
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Jan/Feb 2023
Pg. 72-77
|
Design and Development of Agglomerated Isomalt
Chauhan Nikita N, Patel Jayvadan K
|
Jan/Feb 2023
Pg. 78-87
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 508
|
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
|
Sep/Oct 2022
Pg. 370-377
|
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson, Polonini Hudson
|
Jul/Aug 2022
Pg. 283-291
|
Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 319
|
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2022
Pg. 342-351
|
A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
|
May/Jun 2022
Pg. 195-200
|
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
|
May/Jun 2022
Pg. 255-263
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 141
|
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 142
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 145
|
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 146
|
Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 147
|
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 149
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Mar/Apr 2022
Pg. 155-162
|
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
|
Mar/Apr 2022
Pg. 163-174
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 486-489
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 403-408
|
Calculations
Stockton Shelly J
|
Sep/Oct 2021
Pg. 410
|
Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Jul/Aug 2021
Pg. 288-295
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 304-309
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Jul/Aug 2021
Pg. 344-351
|
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
|
May/Jun 2021
Pg. 218-221
|
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design
Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
|
May/Jun 2021
Pg. 236-240
|
In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D, Dunbar Jacob R
|
May/Jun 2021
Pg. 241-245
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 126-128
|
Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 142
|
Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 143
|
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 144
|
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 145
|
Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom, Taylor Sarah, Zander Clark
|
Mar/Apr 2021
Pg. 156-162
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Calculations
Stockton Shelly J
|
Jan/Feb 2021
Pg. 40
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 45
|
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 46
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S, Schober Joseph M, McPherson Timothy
|
Jan/Feb 2021
Pg. 48-51
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew, Zhao Fang, Dave Vivek S
|
Jan/Feb 2021
Pg. 82-87
|
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 482-490
|
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 501-508
|
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract
Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Nov/Dec 2020
Pg. 509-514
|
Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L.
Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
|
Nov/Dec 2020
Pg. 515-518
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 388-395
|
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
|
Sep/Oct 2020
Pg. 408-412
|
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Sep/Oct 2020
Pg. 413-419
|
Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
|
May/Jun 2020
Pg. 206-212
|
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days
Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
|
May/Jun 2020
Pg. 246-251
|
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
|
May/Jun 2020
Pg. 252-262
|
Compounding Pearls -- Wound Care: Base Selection
Riepl Mike
|
Mar/Apr 2020
Pg. 98-102
|
Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 114-118
|
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 130
|
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 131
|
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 133
|
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 134
|
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 135
|
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 136
|
Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 137
|
Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 138
|
Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 139
|
Feasibility Study of Asthma Cream
Kuang Andrew
|
Mar/Apr 2020
Pg. 163-167
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 38-43
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 472-477
|
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 486
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 488
|
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 489
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 491
|
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 492
|
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 493
|
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 494
|
Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 495
|
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019
Pg. 496-503
|
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
|
Nov/Dec 2019
Pg. 504-510
|
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
|
Nov/Dec 2019
Pg. 519-527
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 393-396
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
|
Jul/Aug 2019
Pg. 288-293
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 299-303
|
Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 305-311
|
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2019
Pg. 221-228
|
Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 135-143
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Orodispersible Film
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 59
|
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Jan/Feb 2019
Pg. 65-69
|
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah, Agu Remigius U
|
Jan/Feb 2019
Pg. 82-87
|
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Cutaia Kara, Chablani Lipika, Zhao Fang
|
Nov/Dec 2018
Pg. 480-489
|
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 492
|
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 493
|
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 494
|
Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 495
|
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 496
|
Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 497
|
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018
Pg. 498-503
|
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018
Pg. 504-511
|
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018
Pg. 516-526
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier
Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha
|
Sep/Oct 2018
Pg. 424-432
|
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding
Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
|
Sep/Oct 2018
Pg. 433-439
|
Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 288-293
|
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 294-300
|
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
|
Jul/Aug 2018
Pg. 303-312
|
Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 316
|
Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson, Carvalho Maria, Banov Fabiana
|
May/Jun 2018
Pg. 182-188
|
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
|
May/Jun 2018
Pg. 220-228
|
Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
|
May/Jun 2018
Pg. 232
|
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations
Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J
|
May/Jun 2018
Pg. 247-251
|
Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 137-143
|
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 146
|
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
|
Mar/Apr 2018
Pg. 164-171
|
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 51
|
Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 52
|
Miconazole 10% in Recura Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 53
|
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 54
|
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 55
|
Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 56
|
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 58
|
Voriconazole 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 59
|
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing
Song Guiyun, Banov Daniel, Bassani August S
|
Jan/Feb 2018
Pg. 60-65
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2017
Pg. 454-461
|
Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
|
Nov/Dec 2017
Pg. 471-479
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
|
Nov/Dec 2017
Pg. 500-512
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 409
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt
Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Sep/Oct 2017
Pg. 430-435
|
Component Selection for Sterile Compounding
Dilzer Richard H
|
Jul/Aug 2017
Pg. 277-280
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Jul/Aug 2017
Pg. 334-338
|
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
|
Jul/Aug 2017
Pg. 339-346
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
|
May/Jun 2017
Pg. 215-220
|
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
|
May/Jun 2017
Pg. 240-241
|
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
|
May/Jun 2017
Pg. 255-263
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017
Pg. 154-159
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
|
Nov/Dec 2016
Pg. 526-527
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
|
Sep/Oct 2016
Pg. 421-425
|
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
|
Sep/Oct 2016
Pg. 426-434
|
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
|
Sep/Oct 2016
Pg. 435-437
|
Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016
Pg. 277-280
|
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Stability of Ampicillin in Normal Saline and Buffered Normal Saline
Maher Moureddine, Jensen Kara J, Lee David, Nix David E
|
Jul/Aug 2016
Pg. 338-342
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John, Light Bob
|
May/Jun 2016
Pg. 250-256
|
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016
Pg. 257-261
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016
Pg. 159-163
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
|
Jan/Feb 2016
Pg. 58-62
|
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016
Pg. 71-80
|
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
|
Jan/Feb 2016
Pg. 81-85
|
Basic Principles of Lyophilization, Part 1
Akers Michael J
|
Nov/Dec 2015
Pg. 471-476
|
Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
|
Nov/Dec 2015
Pg. 479-484
|
Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 411
|
Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 412
|
Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 413
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul
|
Sep/Oct 2015
Pg. 420-427
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Stability of Prednisone in Oral Mix Suspending Vehicle
Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
|
Jul/Aug 2015
Pg. 337-339
|
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015
Pg. 344-347
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
|
Mar/Apr 2015
Pg. 152-160
|
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
|
Mar/Apr 2015
Pg. 161-166
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 38-40
|
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015
Pg. 73-77
|
Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
|
Jan/Feb 2015
Pg. 78-85
|
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014
Pg. 504-511
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014
Pg. 516-519
|
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014
Pg. 520-525
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William, Rudner Shara, Kotik Viktoriya
|
Jul/Aug 2014
Pg. 287-290
|
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014
Pg. 293-300
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 318-319
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Hoffmann Brittany, Carlson Christie, Rao Deepa A
|
Jul/Aug 2014
Pg. 341-344
|
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
Jul/Aug 2014
Pg. 345-347
|
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Addo Richard T
|
Jul/Aug 2014
Pg. 348-350
|
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014
Pg. 213-221
|
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
|
May/Jun 2014
Pg. 228-230
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
|
May/Jun 2014
Pg. 256-261
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 137-138
|
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 42-45
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E, Akbarian-Tefagh Jessica
|
Nov/Dec 2013
Pg. 446-450
|
Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 490-495
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
|
Nov/Dec 2013
Pg. 512-514
|
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan, Black Laura
|
Nov/Dec 2013
Pg. 520-525
|
Chemical Penetration Enhancers
Newton Stephen J
|
Sep/Oct 2013
Pg. 370-374
|
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Pruitt Bobby N III
|
Sep/Oct 2013
Pg. 384-387
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Horace Alexis E, Akbarian-Tefagh Jessica
|
Sep/Oct 2013
Pg. 388-391
|
Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 400-410
|
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013
Pg. 424-431
|
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
|
Sep/Oct 2013
Pg. 432-435
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Stability of Captopril in SyrSPend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 336-338
|
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 344-346
|
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs
Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
|
Jul/Aug 2013
Pg. 347-350
|
Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
|
May/Jun 2013
Pg. 201-204
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Stability of Rifampin in SyrSpend SF
Sorenson Bridget, Whaley Paul
|
Mar/Apr 2013
Pg. 162-164
|
Stability of Minoxidil in Espumil Foam Base
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Mar/Apr 2013
Pg. 165-167
|
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
|
Jan/Feb 2013
Pg. 10-22
|
Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012
Pg. 510-512
|
Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012
Pg. 513-515
|
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations
Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
|
Nov/Dec 2012
Pg. 516-523
|
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
|
Sep/Oct 2012
Pg. 386-393
|
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Peacock Gina F, Sauvageot Jurgita
|
Sep/Oct 2012
Pg. 428-430
|
Selection of Color Additives: A Regulatory View
Kumar Anuj, Dureja Harish, Madan Anil K
|
Jul/Aug 2012
Pg. 304-309
|
Stability of Gabapentin in SyrSpend SF
Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
|
Jul/Aug 2012
Pg. 347-349
|
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Lehman Paul A, Raney Sam G
|
May/Jun 2012
Pg. 248-252
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 146-150
|
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
|
Mar/Apr 2012
Pg. 164-166
|
Stability of Vancomycin in SyrSpend SF
Whaley Paul A, Voudrie Mark A II
|
Mar/Apr 2012
Pg. 167-169
|
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2012
Pg. 62-63
|
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather, Sridhar Vishak, Alexander Kenneth S
|
Nov/Dec 2011
Pg. 510-514
|
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr, Chetia D
|
Nov/Dec 2011
Pg. 521-525
|
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons
James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
|
Sep/Oct 2011
Pg. 390-407
|
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
|
Sep/Oct 2011
Pg. 435-437
|
Quality-Control Analytical Methods: Using Purified Water for Reconstitutions
Biller Jeremy
|
Jul/Aug 2011
Pg. 322-326
|
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles
Voudrie Mark A, Alexander Bridget, Allen D Brett
|
May/Jun 2011
Pg. 255-258
|
Drug Compatibility and Stability in Dextrose vs Saline
Newton David W
|
May/Jun 2011
Pg. 190-192
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011
Pg. 224-232
|
Basics of Compounding: Basics of Compounding with Complex Organic Molecules
Allen Loyd V Jr
|
May/Jun 2011
Pg. 234-238
|
Home Infusion Basics for the Non-Infusion Pharmacist
Miron Karen E
|
Mar/Apr 2011
Pg. 94-100
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1
Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
|
Mar/Apr 2011
Pg. 133-144
|
Basics of Compounding: Basics of Compounding with Inorganic Salts
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 146-153
|
Oral Film Strip Vehicle
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 164
|
Maillard Reactions in Pharmaceutical Formulations and Human Health
Newton David W
|
Jan/Feb 2011
Pg. 32-40
|
Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 508-510
|
Extemporaneous Compounding of Medicated Ointment
Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
|
Nov/Dec 2010
Pg. 472-478
|
Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
|
Jul/Aug 2010
Pg. 276-282
|
Considerations for Percutaneous Absorption
Newton Stephen J, Cook Jennifer M
|
Jul/Aug 2010
Pg. 301-304
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Managing Pain with Transdermal Ketoprofen
Williams KaCee D
|
May/Jun 2010
Pg. 204-206
|
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
McElhiney Linda F
|
Mar/Apr 2010
Pg. 118-123
|
Plasticized Hydrocarbon Gel
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 158
|
Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 159
|
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010
Pg. 21-25
|
Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 72
|
Hydrocarbon-Free Lotion
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 67
|
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle
Gupta Vishnu D
|
Jan/Feb 2010
Pg. 76-77
|
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II, Allen D Brett
|
Jan/Feb 2010
Pg. 82-85
|
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
|
Nov/Dec 2009
Pg. 498-505
|
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William, Angelle Patricea (Patsy), Chang Richard I
|
Nov/Dec 2009
Pg. 506-515
|
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J, Asbill Scott
|
Nov/Dec 2009
Pg. 569-571
|
Twevan Cream
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 561
|
Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009
Pg. 390-391
|
Alcohol-based Carbomer Gel
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 332
|
Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula, Dimassi Hani
|
May/Jun 2009
Pg. 259-261
|
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions
Xu Meng, Warren Flynn W, Bartlett Michael G
|
Mar/Apr 2009
Pg. 166-169
|
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule
Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
|
Mar/Apr 2009
Pg. 170-174
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials
Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
|
Jan/Feb 2009
Pg. 81-86
|
Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
|
Sep/Oct 2008
Pg. 398-401
|
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008
Pg. 460-462
|
Excipient Choices for Special Populations
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008
Pg. 426-430
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
|
Jul/Aug 2008
Pg. 316-320
|
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S, Banov Daniel, Lehman Paul A
|
May/Jun 2008
Pg. 270-273
|
Proteins Used as Sweeteners
Li Xiaojian, Alexander Kenneth S
|
Nov/Dec 2007
Pg. 476-481
|
Nondetergent Neutral Dry Skin Cream
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 425
|
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007
Pg. 426-432
|
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007
Pg. 433-437
|
Vehicle N Formulas
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 337
|
Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
|
Mar/Apr 2007
Pg. 116-120
|
Including Pets in Diabetic Care
Davidson Gigi S
|
Mar/Apr 2007
Pg. 126-130
|
Oral Liquid Vehicle, Anhydrous
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 159
|
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Ford Stephen M, Kloesel Lawson G, Grabenstein John D
|
Mar/Apr 2007
Pg. 164-176
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007
Pg. 5-8
|
Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine, Moffett Brady S
|
Jan/Feb 2007
Pg. 17-19
|
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Davidson Gigi S
|
Nov/Dec 2006
Pg. 405-408
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
|
Sep/Oct 2006
Pg. 392-395
|
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Gupta Vishnu D
|
May/Jun 2006
Pg. 237-239
|
Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
|
Mar/Apr 2006
Pg. 156-158
|
Acacia and Mineral Oil Emulsion NF
Al-Achi Antoine, Mosley Anita, Patlolla Swapna
|
Jan/Feb 2006
Pg. 44
|
Medium-Chain Triglycerides Oral Vehicle, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 63
|
Pediatric Oral Liquid Preparations
Fonseca Simonne C, Ferreira Anderson de O
|
Nov/Dec 2005
Pg. 437-442
|
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
|
Nov/Dec 2005
Pg. 456-461
|
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 462-469
|
Formulating for the Gluten-sensitive Individual
Cacace Janice L
|
Sep/Oct 2005
Pg. 357-358
View Sample |
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration
Landry Christine, Forest Jean-Marc, Hildgen Patrice
|
Sep/Oct 2005
Pg. 396-298
|
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion
Gupta Vishnu D
|
Sep/Oct 2005
Pg. 399-401
|
Physical characteristics of selected over-the-counter medications
Al-Achi Antoine, Shipp Shawnte
|
Jan/Feb 2005
Pg. 75-81
|
Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S, Mitra Pallabi
|
Jan/Feb 2005
Pg. 82-86
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly Ronald F
|
Nov/Dec 2004
Pg. 489-491
|
Featured Excipient: Plasticizers
Allen Loyd V Jr
|
Mar/Apr 2003
Pg. 145-148
|
Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 48-50
|
Featured Excipient: Disinfecting Agents
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 462-464
|
Featured Excipient: Specially Denatured Alcohols
Allen Loyd V Jr
|
Sep/Oct 2002
Pg. 380-383
|
Topical Oil-in-Water Cream Bases, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 303-304
|
Sorbitan Esters, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2002
Pg. 221-223
|
Polysorbates, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 147-148
|
Poloxamers, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2002
Pg. 58-59
|
Tablet and Lozenge Binders, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 471-473
|
Capsule and Tablet Disintegrating Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 389-390
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Official Water-Repelling Agents: The Official Silicones, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2001
Pg. 228
|
Ointment Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 145-146
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
Oleaginous Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 470-472
|
Capsule and Tablet Lubricants, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 390
|
Capsule and Tablet Diluents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 306-310
|
Cellulose Applications for the Pharmaceutical Industry
Nicoll Harold
|
May/Jun 2000
Pg. 196-197
|
Tonicity-Adjusting Agents, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2000
Pg. 218-220
|
Official Solvents, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 139-142
|
Stiffening Agents, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 60-62
|
Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 479
|
Alkalizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 404-405
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Sweetening Agents, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 1999
Pg. 228-231
|
Preservatives, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 142-143
|
Antioxidants, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 52-55
|
Gelatin, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 450-452
|
Dextrose Injection and Dextrose, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 372-373
|
Polyethylene Glycols, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1998
Pg. 306-307
|
Silicates: Attapulgite, Kaolin, Kieselguhr, Magnesium Trisilicate, Pumice, Talc - Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 1998
Pg. 162-164
|
Silicates: Bentonite, Magnesium Aluminum Silicate, Silica Gel and Colloidal Silicon Dioxide - , Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 73-74
|
Water, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 1997
Pg. 426-427
|
Benzalkonium Chloride, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 1997
Pg. 336-337
|
Poloxamer, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 1997
Pg. 190-191
|
Methylcellulose, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 115
|
| Return to Top |
